arrow
N

Nicholas Lintzeris

new south wales drug and alcohol clinical research and improvement network
H指数:48
被引数:8,249

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Acting Injectable Buprenorphine in Prison: Insights From a Short-Answer Survey of People in the Criminal Justice System Commencing Long-Acting Injectable Buprenorphine During a Non-Randomised Clinical Trial

长期注射用丁丙诺啡在监狱中的应用:来自刑事司法系统中接受长期注射用丁丙诺啡的非随机临床试验参与者的简答题调查的见解

2026-09-230
OA
Responsible preoperative opioid use for hip or knee arthroplasty (OpioidHALT): a protocol for a randomised clinical trial of pharmacist-partnered opioid tapering prior to hip or knee arthroplasty

髋或膝关节置换术前负责任阿片类药物使用(OpioidHALT):一项关于药师合作在髋或膝关节置换术前进行阿片类药物减量的随机临床试验方案

2026-05-130
PRE
Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settings

研究随机对照试验方案,以确定右赖苯甲酸安非他命在住院环境下治疗急性甲基苯丙胺戒断的疗效。

2025-11-260
PRE
Impact of dextroamphetamine substitution on the use of illicit amphetamines in adults with amphetamine dependence: a study protocol for the multicentre double blind randomised controlled trial ATLAS4Dependence
2025-10-200
OA
Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short-Acting Injectable Opioid Treatment in Australia

氢吗啡酮的希望:一项关于在澳大利亚开始接受监督下短效注射阿片类药物治疗的定性研究

2025-06-030
OA
Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in Australia

弥合证据与政治:澳大利亚监督注射阿片类药物治疗(SIOT)的实施试验

2025-04-010
OAAI
Design Considerations for Medicinal Cannabis Clinical Trials in People Receiving Palliative Care

姑息治疗患者中医疗大麻临床试验的设计考虑

2025-02-010
OAAI
Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial

Lisdexamfetamine治疗甲基苯丙胺依赖: 一项随机,安慰剂对照试验

2024-12-190
OAAI